福元医药
(601089)
| 流通市值：80.06亿 | | | 总市值：80.06亿 |
| 流通股本：4.80亿 | | | 总股本：4.80亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 830,471,781.49 | 3,445,642,486.39 | 2,547,022,297.14 | 1,655,495,417.22 |
| 营业收入 | 830,471,781.49 | 3,445,642,486.39 | 2,547,022,297.14 | 1,655,495,417.22 |
| 二、营业总成本 | 698,838,652.84 | 2,942,075,836.89 | 2,143,616,163.4 | 1,362,185,010.9 |
| 营业成本 | 277,010,538.45 | 1,133,990,086.45 | 838,284,084.34 | 551,392,156.59 |
| 税金及附加 | 8,000,488.64 | 33,917,505.12 | 25,148,852.12 | 16,300,060.01 |
| 销售费用 | 305,932,114.23 | 1,256,108,201.94 | 917,476,764.29 | 574,751,256.71 |
| 管理费用 | 35,622,099.52 | 135,909,600.14 | 94,368,474.11 | 57,383,623.03 |
| 研发费用 | 74,193,792.66 | 417,370,397.1 | 297,591,745.37 | 189,441,111.65 |
| 财务费用 | -1,920,380.66 | -35,219,953.86 | -29,253,756.83 | -27,083,197.09 |
| 其中:利息费用 | 519,885.21 | 3,503,320.64 | 2,800,493.52 | 2,005,160.82 |
| 其中:利息收入 | 2,432,737.61 | 38,483,474.83 | 32,122,065.94 | 29,041,462.87 |
| 加:投资收益 | 8,751,677.53 | 10,767,760.71 | 4,378,593.51 | -301,441.08 |
| 资产处置收益 | -17,127.83 | 1,037,530.39 | 8,538,534.22 | 8,439,699.79 |
| 资产减值损失(新) | -747,017.2 | -10,682,920.78 | -4,072,659.8 | -1,456,900.33 |
| 信用减值损失(新) | -256,947.86 | -1,317,605.33 | -752,226.13 | 31,233.71 |
| 其他收益 | 5,060,086.74 | 39,157,193.39 | 23,782,481.55 | 19,019,296.28 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 144,423,800.03 | 542,528,607.88 | 435,280,857.09 | 319,042,294.69 |
| 加:营业外收入 | 209,312.69 | 2,545,516.39 | 1,948,564.78 | 1,749,350.73 |
| 减:营业外支出 | 310,061.66 | 4,958,926.35 | 3,925,826 | 2,172,084 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 144,323,051.06 | 540,115,197.92 | 433,303,595.87 | 318,619,561.42 |
| 减:所得税费用 | 13,517,646.32 | 48,037,599.53 | 29,222,344.75 | 26,180,833.45 |
| 六、净利润 | 130,805,404.74 | 492,077,598.39 | 404,081,251.12 | 292,438,727.97 |
| 持续经营净利润 | 130,805,404.74 | 492,077,598.39 | 404,081,251.12 | 292,438,727.97 |
| 归属于母公司股东的净利润 | 130,633,035.22 | 488,674,918.14 | 400,949,905.3 | 290,621,292.44 |
| 少数股东损益 | 172,369.52 | 3,402,680.25 | 3,131,345.82 | 1,817,435.53 |
| (一)基本每股收益 | 0.27 | 1.04 | 0.85 | 0.61 |
| (二)稀释每股收益 | 0.27 | 1.04 | 0.85 | 0.61 |
| 九、综合收益总额 | 130,805,404.74 | 492,077,598.39 | 404,081,251.12 | 292,438,727.97 |
| 归属于母公司股东的综合收益总额 | 130,633,035.22 | 488,674,918.14 | 400,949,905.3 | 290,621,292.44 |
| 归属于少数股东的综合收益总额 | 172,369.52 | 3,402,680.25 | 3,131,345.82 | 1,817,435.53 |
| 公告日期 | 2025-04-30 | 2025-04-01 | 2024-10-25 | 2024-08-15 |
| 审计意见(境内) | | 标准无保留意见 | | |